MedAlliance: A Game-Changing Acquisition by Cordis in a Groundbreaking $1.135bn Deal!
Cordis, a developer and manufacturer of interventional cardiovascular and endovascular technologies, has recently acquired Swiss medical technology
Medalliance Microreservoir Cell Adhesion Technology Sustained Limus Release Limus Drug Eluting Stent Medtech News
Source: compsmag.com